Vicenta Martínez Zorzano-rekin lankidetzan egindako argitalpenak (11)

2022

  1. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

    Cancers, Vol. 14, Núm. 19

2018

  1. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples

    Clinical Epigenetics, Vol. 10, Núm. 1

  2. Proteomic profiling for colorectal cancer biomarker discovery

    Methods in Molecular Biology (Humana Press Inc.), pp. 241-269

2016

  1. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer

    Scientific Reports, Vol. 6

2015

  1. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening

    Scientific Reports, Vol. 5

  2. Serum sCD26 for colorectal cancer screening in family-risk individuals: Comparison with faecal immunochemical test

    British Journal of Cancer, Vol. 112, Núm. 2, pp. 375-381

2014

  1. Niveles séricos de metalopretasa-9 en individuos con riesgo familiar de cáncer colorrectal

    Investigación: cultura, ciencia y tecnología, Núm. 11, pp. 8-13

  2. Nonhomogeneous silica promotes the biologically induced delivery of metal ions from silica-coated magnetic nanoparticles

    Journal of Physical Chemistry C, Vol. 118, Núm. 48, pp. 28266-28273

2013

  1. Decreased expression of alpha-L-fucosidase gene FUCA1 in human colorectal tumors

    International Journal of Molecular Sciences, Vol. 14, Núm. 8, pp. 16986-16998

2012

  1. Magnetic silica nanoparticle cellular uptake and cytotoxicity regulated by electrostatic polyelectrolytes-DNA loading at their surface

    ACS Nano, Vol. 6, Núm. 1, pp. 747-759

2008

  1. Cytotoxicity of selected imidazolium-derived ionic liquids in the human Caco-2 cell line. Sub-structural toxicological interpretation through a QSAR study

    Green Chemistry, Vol. 10, Núm. 5, pp. 508-51